Nutrineal Pd4 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The blend provides the nine essential amino acids that the body cannot synthesize. These amino acids become building blocks for protein synthesis, help maintain nitrogen balance, support tissue repair, and contribute to metabolic processes when delivered directly into the bloodstream.

The prescribed dose of Nutrineal Pd4 is individualized by the treating physician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. No fixed regimen is provided; dosing is determined by the healthcare professional.

Safety data for Nutrineal Pd4 in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing clinician.

To order Nutrineal Pd4, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Nutrineal Pd4 offers a comprehensive profile of essential amino acids in a single sterile solution, matching the composition of many standard TPN amino acid formulations. Compared with multi‑component kits, it simplifies preparation but should still be evaluated for compatibility with other IV admixtures used in a specific clinical protocol.

Nutrineal Pd4 must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Inspect the product before use for any particulate matter or discoloration.

Nutrineal Pd4 is administered as a sterile solution for injection. It is typically infused intraperitoneally or intravenously using aseptic technique, under the supervision of qualified healthcare personnel, and the infusion rate is set according to the patient’s nutritional plan.

The most serious risks include metabolic acidosis, severe allergic reactions such as anaphylaxis, and renal dysfunction, especially in patients with pre‑existing kidney disease. Prompt recognition and appropriate medical intervention are essential if any of these events occur.

Nutrineal Pd4 should be avoided in patients with known hypersensitivity to any of its amino acid components, in those with severe uncontrolled renal failure, or in individuals where the risk of fluid overload outweighs the nutritional benefit. Clinical judgment is required for all contraindications.